Back
CRISPR Therapeutics AG Stock Price Chart
These 7 Stocks Will Be Magnificent in 2025
Get Your Copy of "These 7 Stocks Will Be Magnificent in 2025" Here.
Sell
28
CRSP
CRISPR Therapeutics AG
Last Price:
$40.74
Seasonality Move:
16.92%
7 Day Trial
ALL ACCESS PASS
$
7
The AI Energy Miracle
Details Here.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRSP is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRISPR Therapeutics AG Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 43.5 | Sell |
| 20-day SMA: | 47.77 | Sell |
| 50-day SMA: | 48.31 | Sell |
| 200-day SMA: | 53.99 | Sell |
| 8-day EMA: | 43.38 | Sell |
| 20-day EMA: | 46.13 | Sell |
| 50-day EMA: | 47.73 | Sell |
| 200-day EMA: | 52.28 | Sell |
CRISPR Therapeutics AG Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.05 | Sell |
| Relative Strength Index (14 RSI): | 33.92 | Sell |
| Chaikin Money Flow: | 1963017 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.97 - 51.27) | Sell |
| Bollinger Bands (100): | (45.2 - 50.74) | Sell |
CRISPR Therapeutics AG Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for CRISPR Therapeutics AG Stock
Is CRISPR Therapeutics AG Stock a Buy?
-
CRISPR Therapeutics AG share price is 40.72 while CRSP 8-day simple moving average is 43.50, which is a Sell signal.
-
The stock price of CRSP is 40.72 while CRISPR Therapeutics AG 20-day SMA is 47.77, which makes it a Sell.
-
CRISPR Therapeutics AG 50-day simple moving average is 48.31 while CRSP share price is 40.72, making it a Sell technically.
-
CRSP stock price is 40.72 and CRISPR Therapeutics AG 200-day simple moving average is 53.99, creating a Sell signal.
CRSP Technical Analysis vs Fundamental Analysis
Sell
28
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy or a Sell?
-
CRISPR Therapeutics AG stock is rated a SellThe current CRISPR Therapeutics AG [CRSP] share price is $40.72. The Score for CRSP is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
CRISPR Therapeutics AG Stock Info
Market Cap:
3.5B
Price in USD:
40.72
Share Volume:
3.1M
CRISPR Therapeutics AG 52-Week Range
52-Week High:
91.10
52-Week Low:
39.41
Sell
28
CRISPR Therapeutics AG (CRSP)
is a Sell
CRISPR Therapeutics AG Share Price Forecast
-
What is the CRISPR Therapeutics AG stock price today?The CRISPR Therapeutics AG stock price is 40.72 USD today.
-
Will CRSP stock go up or go down?CRISPR Therapeutics AG> share price is forecast to RISE/FALL based on technical indicators
-
Is CRISPR Therapeutics AG overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, CRISPR Therapeutics AG is overvalued.
Is CRISPR Therapeutics AG Stock a Buy?
-
CRISPR Therapeutics AG share price is 40.72 while CRSP 8-day exponential moving average is 43.38, which is a Sell signal.
-
The stock price of CRSP is 40.72 while CRISPR Therapeutics AG 20-day EMA is 46.13, which makes it a Sell.
-
CRISPR Therapeutics AG 50-day exponential moving average is 47.73 while CRSP share price is 40.72, making it a Sell technically.
-
CRSP stock price is 40.72 and CRISPR Therapeutics AG 200-day simple moving average is 52.28, creating a Sell signal.
Fundamental Analysis of CRISPR Therapeutics AG
Is CRISPR Therapeutics AG a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.20 per share, and an increase next year of $0.14 per share.
Technical Analysis of CRISPR Therapeutics AG
Should I short CRISPR Therapeutics AG stock?
-
CRSP Moving Average Covergence Divergence (MACD) indicator is -2.05, suggesting CRISPR Therapeutics AG is a Sell
-
CRISPR Therapeutics AG Relative Strength Index (RSI) is 33.92, which suggest CRISPR Therapeutics AG is oversold
-
The Bollinger Bands (25) for CRISPR Therapeutics AG is (43.97 - 51.27), which suggest CRISPR Therapeutics AG is a Sell
-
The Bollinger Bands (100) for CRISPR Therapeutics AG is (45.2 - 50.74), which suggest CRISPR Therapeutics AG is a Sell
* CRISPR Therapeutics AG stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.